Quick Answer
Teladoc Health, Inc. reported Operating Income Loss of -$262.96 million for the year ending 2025.
- Teladoc Health, Inc. showed an increase of +74.2% in Operating Income Loss from 2024 to 2025.
- This data is from Teladoc Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: -$2.86 million | Q3 2014: -$3.86 million | Q1 2015: -$12.59 million | Q2 2015: -$16.25 million | Q3 2015: -$12.60 million | Q1 2016: -$14.72 million | Q2 2016: -$14.46 million | Q3 2016: -$20.26 million | Q4 2016: -$13.23 million | Q1 2017: -$14.80 million | Q2 2017: -$14.49 million | Q3 2017: -$21.54 million | Q4 2017: -$24.56 million | Q1 2018: -$19.09 million | Q2 2018: -$18.15 million | Q3 2018: -$15.78 million | Q4 2018: -$17.84 million | Q1 2019: -$22.89 million | Q2 2019: -$22.02 million | Q3 2019: -$19.94 million | Q4 2019: -$15.59 million | Q1 2020: -$21.01 million | Q2 2020: -$7.18 million | Q3 2020: -$19.73 million | Q1 2021: -$84.68 million | Q2 2021: -$78.95 million | Q3 2021: -$60.58 million | Q1 2022: -$6.67 billion | Q2 2022: -$3.10 billion | Q3 2022: -$71.73 million | Q1 2023: -$77.10 million | Q2 2023: -$71.65 million | Q3 2023: -$64.73 million | Q1 2024: -$87.12 million | Q2 2024: -$841.15 million | Q3 2024: -$44.40 million | Q1 2025: -$120.61 million | Q2 2025: -$54.39 million | Q3 2025: -$51.96 million.
- Over the full 13 years of available data (2013 to 2025), Teladoc Health, Inc.'s Operating Income Loss has declined by 4,380.4%.
- Historical annual values: Fiscal year 2025: -$262.96 million | Fiscal year 2024: -$1.02 billion | Fiscal year 2023: -$248.55 million | Fiscal year 2022: -$13.65 billion | Fiscal year 2021: -$265.63 million | Fiscal year 2020: -$506.42 million | Fiscal year 2019: -$80.44 million | Fiscal year 2018: -$70.85 million | Fiscal year 2017: -$75.39 million | Fiscal year 2016: -$62.66 million | Fiscal year 2015: -$55.79 million | Fiscal year 2014: -$15.15 million | Fiscal year 2013: -$5.87 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: